Functional Recovery of Damaged Skeletal Muscle Through Synchronized Vasculogenesis, Myogenesis, and Neurogenesis by Muscle-Derived Stem Cells
- 1 November 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 112 (18), 2857-2866
- https://doi.org/10.1161/circulationaha.105.554832
Abstract
Background—Recent studies have shown that skeletal muscle–derived stem cells (MDSCs) can give rise to several cell lineages after transplantation. However, the potential therapeutic uses of MDSCs, the functional significance of the transplanted tissue, and vasculogenesis, myogenesis, and reconstitution of other tissues have yet to be investigated in detail. In addition, the relationship between MDSCs and mesenchymal bone marrow cells is of interest.Methods and Results—We developed a severe-damage model of mouse tibialis anterior muscle with a large deficit of nerve fibers, muscle fibers, and blood vessels. We investigated the potential therapeutic use of freshly isolated CD34+/45−(Sk-34) cells. Results showed that, after transplantation, implanted cells give rise to myogenic, vascular (pericytes, vascular smooth muscle cells, and endothelial cells), and neural (Schwann) cells, as well as contributing to the synchronized reconstitution of blood vessels, muscle fibers, and peripheral nerves, with significant recovery of both mass and contractile function after transplantation. Investigation of Sk-34 cell transplantation to the renal capsule (nonmuscle tissue) and fluorescence in situ hybridization analysis for the transplanted muscle detecting the Y chromosome revealed the intrinsic plasticity of the Sk-34 cell population. In addition, there were no donor-derived Sk-34 cells in the muscle of lethally irradiated bone marrow–transplanted animals, indicating that the Sk-34 cells were not derived from bone marrow.Conclusions—These findings indicate that freshly isolated skeletal muscle–derived Sk-34 cells are potentially useful for reconstitution therapy of the vascular, muscular, and peripheral nervous systems. These results provide new insights into somatic stem and/or progenitor cells with regard to vasculogenesis, myogenesis, and neurogenesis.This publication has 19 references indexed in Scilit:
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004
- Myoendothelial Differentiation of Human Umbilical Cord Blood–Derived Stem Cells in Ischemic Limb TissuesCirculation Research, 2003
- Cell fusion is the principal source of bone-marrow-derived hepatocytesNature, 2003
- Neuronal differentiation of stem cells isolated from adult muscleJournal of Neuroscience Research, 2002
- Determination of bone marrow–derived endothelial progenitor cell significance in angiogenic growth factor–induced neovascularization in vivoExperimental Hematology, 2002
- Identification of a novel population of muscle stem cells in miceThe Journal of cell biology, 2002
- Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscleThe Journal of cell biology, 2002
- Bone marrow origin of hematopoietic progenitors and stem cells in murine muscleBlood, 2001
- Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donorsThe Anatomical Record, 2001
- Dystrophin expression in the mdx mouse restored by stem cell transplantationNature, 1999